Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul 1;74(7):857-865.
doi: 10.1001/jamaneurol.2017.0643.

Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study

Manuel M Montero-Odasso  1 , Yanina Sarquis-Adamson  2 , Mark Speechley  3 , Michael J Borrie  4 , Vladimir C Hachinski  5 , Jennie Wells  4 , Patricia M Riccio  6 , Marcelo Schapira  7 , Ervin Sejdic  8 , Richard M Camicioli  9 , Robert Bartha  10 , William E McIlroy  11 , Susan Muir-Hunter  12
Affiliations

Association of Dual-Task Gait With Incident Dementia in Mild Cognitive Impairment: Results From the Gait and Brain Study

Manuel M Montero-Odasso et al. JAMA Neurol. .

Erratum in

  • Error in Discussion Section.
    [No authors listed] [No authors listed] JAMA Neurol. 2017 Nov 1;74(11):1381. doi: 10.1001/jamaneurol.2017.2722. JAMA Neurol. 2017. PMID: 28975243 Free PMC article. No abstract available.

Abstract

Importance: Gait performance is affected by neurodegeneration in aging and has the potential to be used as a clinical marker for progression from mild cognitive impairment (MCI) to dementia. A dual-task gait test evaluating the cognitive-motor interface may predict dementia progression in older adults with MCI.

Objective: To determine whether a dual-task gait test is associated with incident dementia in MCI.

Design, setting, and participants: The Gait and Brain Study is an ongoing prospective cohort study of community-dwelling older adults that enrolled 112 older adults with MCI. Participants were followed up for 6 years, with biannual visits including neurologic, cognitive, and gait assessments. Data were collected from July 2007 to March 2016.

Main outcomes and measures: Incident all-cause dementia was the main outcome measure, and single- and dual-task gait velocity and dual-task gait costs were the independent variables. A neuropsychological test battery was used to assess cognition. Gait velocity was recorded under single-task and 3 separate dual-task conditions using an electronic walkway. Dual-task gait cost was defined as the percentage change between single- and dual-task gait velocities: ([single-task gait velocity - dual-task gait velocity]/ single-task gait velocity) × 100. Cox proportional hazard models were used to estimate the association between risk of progression to dementia and the independent variables, adjusted for age, sex, education, comorbidities, and cognition.

Results: Among 112 study participants with MCI, mean (SD) age was 76.6 (6.9) years, 55 were women (49.1%), and 27 progressed to dementia (24.1%), with an incidence rate of 121 per 1000 person-years. Slow single-task gait velocity (<0.8 m/second) was not associated with progression to dementia (hazard ratio [HR], 3.41; 95% CI, 0.99-11.71; P = .05)while high dual-task gait cost while counting backward (HR, 3.79; 95% CI, 1.57-9.15; P = .003) and naming animals (HR, 2.41; 95% CI, 1.04-5.59; P = .04) were associated with dementia progression (incidence rate, 155 per 1000 person-years). The models remained robust after adjusting by baseline cognition except for dual-task gait cost when dichotomized.

Conclusions and relevance: Dual-task gait is associated with progression to dementia in patients with MCI. Dual-task gait testing is easy to administer and may be used by clinicians to decide further biomarker testing, preventive strategies, and follow-up planning in patients with MCI.

Trial registration: clinicaltrials.gov: NCT03020381.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Wells reports that she was a part-time employee for Pfizer pharmaceuticals and owns stock employee options. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Cumulative Hazard Ratio for Progression to Dementia for Low and High Dual-Task Cost in Gait Velocity (n = 112)
A, Dual-task gait cost (DTC) while counting backward. B, While performing serial sevens subtractions. C, While naming animals.
Figure 2.
Figure 2.. Risk of Dementia Stratified by Gait Velocity (Centimeters per Second) Quartiles in 3 Dual-Tasks Conditions
The 3 dual-tasks conditions are counting backward (A), serial sevens subtractions (B), and naming animals (C).
Figure 3.
Figure 3.. Proposal That Dual-Task Gait Could Be an Early Clinical Marker of Progression to Dementia Syndromes
See this image and copyright information in PMC

Comment in

References

    1. Petersen RC. Clinical practice: mild cognitive impairment. N Engl J Med. 2011;364(23):2227-2234. - PubMed
    1. Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer’s disease. Neurology. 2002;59(7):1034-1041. - PubMed
    1. Winblad B, Palmer K, Kivipelto M, et al. Mild cognitive impairment: beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med. 2004;256(3):240-246. - PubMed
    1. Montero-Odasso M, Bergman H, Phillips NA, Wong CH, Sourial N, Chertkow H. Dual-tasking and gait in people with mild cognitive impairment: the effect of working memory. BMC Geriatr. 2009;9:41. - PMC - PubMed
    1. Aggarwal NT, Wilson RS, Beck TL, Bienias JL, Bennett DA. Motor dysfunction in mild cognitive impairment and the risk of incident Alzheimer disease. Arch Neurol. 2006;63(12):1763-1769. - PubMed

Publication types

Associated data